Come hang out with the community for the next session of our Start-Up Stories series! 

Altera is on a mission to redesign the rules of compatibility by building a universal donor cell platform designed to enable scalable, immune-compatible, off-the-shelf allogeneic therapies for cell and tissue transplantation. Their mission is to remove the barriers of immunogenicity and donor-matching through cell engineering, making cell therapy more scalable, accessible, and impactful across the globe.

We’re thrilled to welcome Alex & Micheal from Altera Biosciences.

This is your chance to hear the human side of biotech innovation, ask your burning questions, and meet fellow builders in the community over a great lunch.